Clinical Trial Update: A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

A multicenter, prospective Phase 2 cohort trial evaluating Trop-2 antibody-drug conjugate combination therapy for advanced triple-negative breast cancer, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Trop-2 ADC (investigational) (Trop-2 antibody-drug conjugate)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer | Phase 2 | Status: RECRUITING